Remote Ischaemic Preconditioning for Heart Surgery (RIPHeart-Study)
Remote Ischaemic Preconditioning for Heart Surgery
Sponsor: German Research Foundation
Terminated
This trial was terminated. No reason was provided.
This PHASE3 trial investigates Mortality and Myocardial Injury and is currently terminated or withdrawn. German Research Foundation leads this study, which shows 9 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Mar 2023 — Jul 2024 [monthly]
Terminated PHASE3
-
May 2022 — Mar 2023 [monthly]
Terminated PHASE3
▶ Show 4 earlier versions
-
Jan 2021 — May 2022 [monthly]
Terminated PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE3
-
Jun 2018 — Nov 2020 [monthly]
Terminated PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE3
First recorded
Dec 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- German Research Foundation
- Goethe University
- University Hospital Schleswig-Holstein
For direct contact, visit the study record on ClinicalTrials.gov .